SEC Form 3 · accession 0001615219-17-000082
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger D Tung
Director
Period of report
Oct 30, 2017
Accepted (ET)
Nov 6, 2017 · 1:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,837 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.60 | holding | — | — | — | — | Apr 9, 2024 | Common Stock | 4,670 | — | D |
| Stock Option (right to buy)F2 | $5.44 | holding | — | — | — | — | Nov 14, 2024 | Common Stock | 4,670 | — | D |
Explanation of responses
- F125% of the total shares underlying this option vested on April 9, 2015 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.
- F225% of the total shares underlying this option vested on November 14, 2015 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.
Remarks
Exhibit 24.1 - Power of Attorney